GB1356937A - Pyrimido-isoquinolines - Google Patents

Pyrimido-isoquinolines

Info

Publication number
GB1356937A
GB1356937A GB4140270A GB4140270A GB1356937A GB 1356937 A GB1356937 A GB 1356937A GB 4140270 A GB4140270 A GB 4140270A GB 4140270 A GB4140270 A GB 4140270A GB 1356937 A GB1356937 A GB 1356937A
Authority
GB
United Kingdom
Prior art keywords
pyrimido
compounds
aug
isoquinolines
dihydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB4140270A
Other languages
English (en)
Inventor
H F Hodson
A W Randall
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Priority to GB4140270A priority Critical patent/GB1356937A/en
Priority to CA121,468A priority patent/CA977343A/en
Priority to IE1082/71A priority patent/IE35570B1/xx
Priority to FR7131030A priority patent/FR2103559B1/fr
Priority to AU32762/71A priority patent/AU465829B2/en
Priority to DE19712142792 priority patent/DE2142792A1/de
Priority to NL7111759A priority patent/NL7111759A/xx
Priority to US00175329A priority patent/US3792050A/en
Priority to ES394546A priority patent/ES394546A1/es
Priority to IL37588A priority patent/IL37588A/en
Priority to SE7110810A priority patent/SE373138B/xx
Priority to AR237590A priority patent/AR192890A1/es
Priority to ZA715701A priority patent/ZA715701B/xx
Priority to HUWE000443 priority patent/HU164176B/hu
Priority to BE771911A priority patent/BE771911A/xx
Priority to AR241935A priority patent/AR193522A1/es
Priority to AR241934A priority patent/AR195669A1/es
Priority to US306716A priority patent/US3876788A/en
Priority to ES422327A priority patent/ES422327A1/es
Publication of GB1356937A publication Critical patent/GB1356937A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
GB4140270A 1970-08-27 1970-08-27 Pyrimido-isoquinolines Expired GB1356937A (en)

Priority Applications (19)

Application Number Priority Date Filing Date Title
GB4140270A GB1356937A (en) 1970-08-27 1970-08-27 Pyrimido-isoquinolines
CA121,468A CA977343A (en) 1970-08-27 1971-08-26 Heterocyclic compounds
IE1082/71A IE35570B1 (en) 1970-08-27 1971-08-26 Pyrimido isoquinolines
FR7131030A FR2103559B1 (enExample) 1970-08-27 1971-08-26
AU32762/71A AU465829B2 (en) 1970-08-27 1971-08-26 Heterocyclic compounds
DE19712142792 DE2142792A1 (de) 1970-08-27 1971-08-26 Heterocyclische Verbindungen
NL7111759A NL7111759A (enExample) 1970-08-27 1971-08-26
US00175329A US3792050A (en) 1970-08-27 1971-08-26 2-oxo-2h-pyrimido(2,1-a)isoquinoline
ES394546A ES394546A1 (es) 1970-08-27 1971-08-26 Procedimiento para la preparacion de pirimido (2 1-a) iso- quinoleinas.
IL37588A IL37588A (en) 1970-08-27 1971-08-26 2h-pyrimido (2,1-a) isoquinolin-2-ones,their preparation and pharmaceutical compositions containing them
SE7110810A SE373138B (enExample) 1970-08-27 1971-08-26
AR237590A AR192890A1 (es) 1970-08-27 1971-08-26 Un procedimiento para la preparacion de pirimida(2,1-a)isoquinolinas
ZA715701A ZA715701B (en) 1970-08-27 1971-08-26 Heterocyclic compounds
HUWE000443 HU164176B (enExample) 1970-08-27 1971-08-27
BE771911A BE771911A (fr) 1970-08-27 1971-08-27 Composes heterocycliques
AR241935A AR193522A1 (es) 1970-08-27 1972-05-11 Un procedimiento para la preparacion de pirimido(2,1-a)isoquinolinas
AR241934A AR195669A1 (es) 1970-08-27 1972-05-11 Un procedimiento para la preparacion de pirimido <2,1-a> isoquinolinas
US306716A US3876788A (en) 1970-08-27 1972-11-15 Heterocyclic compounds in the treatment of inflammatory of arthritic conditions
ES422327A ES422327A1 (es) 1970-08-27 1974-01-16 Un procedimiento para la preparacion de pirimido (2,1-a) i-soquinoleinas.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB4140270A GB1356937A (en) 1970-08-27 1970-08-27 Pyrimido-isoquinolines
GB5678170 1970-11-30

Publications (1)

Publication Number Publication Date
GB1356937A true GB1356937A (en) 1974-06-19

Family

ID=26264669

Family Applications (1)

Application Number Title Priority Date Filing Date
GB4140270A Expired GB1356937A (en) 1970-08-27 1970-08-27 Pyrimido-isoquinolines

Country Status (12)

Country Link
US (1) US3792050A (enExample)
AR (3) AR192890A1 (enExample)
BE (1) BE771911A (enExample)
CA (1) CA977343A (enExample)
DE (1) DE2142792A1 (enExample)
ES (2) ES394546A1 (enExample)
FR (1) FR2103559B1 (enExample)
GB (1) GB1356937A (enExample)
IE (1) IE35570B1 (enExample)
IL (1) IL37588A (enExample)
NL (1) NL7111759A (enExample)
SE (1) SE373138B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3868378A (en) * 1973-06-06 1975-02-25 Morton Norwich Products Inc Imidazo {8 4,5-f{9 {0 quinolin-9-ols
US3919238A (en) * 1973-06-06 1975-11-11 Morton Norwich Products Inc 9-(Substituted amino)imidazo(4,5-f) quinolines
US4017625A (en) * 1975-08-01 1977-04-12 Pfizer Inc. Anti-allergic N-(5-tetrazolyl)-1-oxo-1H-6-alkoxypyrimido-[1,2-a]quinoline-2-carboxamides and intermediates therefor
US4127720A (en) * 1977-09-21 1978-11-28 Bristol-Myers Company Pyrimido[2,1-a]isoquinoline derivatives having antiallergy activity

Also Published As

Publication number Publication date
ES422327A1 (es) 1976-08-01
FR2103559B1 (enExample) 1974-09-06
NL7111759A (enExample) 1972-02-29
SE373138B (enExample) 1975-01-27
DE2142792A1 (de) 1972-03-02
US3792050A (en) 1974-02-12
CA977343A (en) 1975-11-04
FR2103559A1 (enExample) 1972-04-14
BE771911A (fr) 1972-12-28
IE35570B1 (en) 1976-03-18
AR195669A1 (es) 1973-10-31
IL37588A0 (en) 1971-11-29
AR192890A1 (es) 1973-03-21
AR193522A1 (es) 1973-04-30
ES394546A1 (es) 1974-09-01
IL37588A (en) 1974-09-10

Similar Documents

Publication Publication Date Title
GB1508015A (en) Derivatives of pyrrolidine and piperidine
GB1398455A (en) Quinazoline compounds
GB1373212A (en) Pyrazole compounds
GB1356937A (en) Pyrimido-isoquinolines
GB1415601A (en) Dihydrobetulinic acid derivatives
GB1431414A (en) Prostanoic acid derivatives
GB1186495A (en) 0-[3-(4-Fluorobenzoyl) Proplyl]-4-Substituted Piperazines, their Acid Addition Salts and their method of preparation
GB1529403A (en) Isoxazole derivative
GB1278626A (en) New imidazolidinones their preparation and compositions containing same
GB1473971A (en) 3-hydroxy-5,6-benzomorphinan derivatives
ES405385A1 (es) Un metodo de producir preparaciones farmaceuticas.
GB1476053A (en) Glycyrrhetinic acid derivatives
ES8507506A1 (es) Procedimiento para la obtencion de derivados de diaril-imidazol.
ES8100282A1 (es) Procedimiento para la obtencion de nuevos derivados de la piperacina metanimina
GB1386210A (en) 2-methyl-5 nitro-1- 2-heteroaryloxy-ethyl imidazoles
GB1492163A (en) Triazolobenzocycloalkylthiadiazine derivatives
GB1454666A (en) Pyrido 2,3-d- pyrimidinethiones
GB1421554A (en) Process for the stereoselective production of intermediates in the synthesis of pgea and derivatives
GB1373333A (en) Pyrazole derivatives
GB1457911A (en) Guanyl-hydrazones
GB1504683A (en) Pharmaceutical compositions containing substituted pyrimido-quinoline derivatives
SE7408868L (enExample)
GB1393979A (en) Piperidine derivatives
GB1409936A (en) Prostaglandin-type compounds
GB1501588A (en) 4,5-disubstituted 2-oxazolealkanoic acids esters and alkali metal salts

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee